🇪🇺 VILOBELIMAB in European Union

VILOBELIMAB (VILOBELIMAB) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/006123
  • Local brand name: Gohibic
  • Status: approved

VILOBELIMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is VILOBELIMAB approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for VILOBELIMAB in European Union?

Marketing authorisation holder not available in our data.